Understanding coping strategies in children with cancer and their parents
Official title: Coping and Attachment in Pediatric Oncohematology: Multicenter Cross-sectional Study to Assess Emotional Resources and Attachment Dynamics Related to Coping Strategies in Parents of Children With Oncohematologic Disease
Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06858163 · Data updated 2026-11-12
This study looks at how children with cancer and their parents handle the illness together to see what helps them cope better during treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 8 Years to 17 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 3 sites (Monza, Monza-Brianza and 2 other locations) |
| Status | Recruiting |
| Started | July 12, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT06858163 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children aged 8 to 17 undergoing treatment for cancer and their parents who are fluent in Italian.
✕Probably not a fit
Patients who are off-therapy or do not have a parent participating in the study may not benefit from this research.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study examines how pediatric cancer patients cope with their illness and how this is influenced by their relationships with their parents. It focuses on the interaction between parental coping strategies and child coping behaviors, aiming to identify the factors that contribute to effective coping in the context of pediatric oncology. The study will involve parents and children aged 8 to 17 who are currently undergoing treatment in specific pediatric oncohematology departments. By analyzing these dynamics, the research seeks to provide insights into improving support for families dealing with pediatric cancer.
Why it matters
Potential benefit: If successful, this study could enhance coping strategies for both children and parents, leading to better psychological outcomes during cancer treatment.
How similar studies have gone: Previous studies in oncology have shown that understanding coping strategies can significantly impact patient and family outcomes, suggesting that this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Parents Inclusion Criteria: * parents of both sexes * age of son/daughter between 8 and 17 years old (included) * son/daughter being treated at the Pediatric Oncohematology departments involved in the research (Day Hospital and hospitalization) * good understanding of the Italian language Parents Exclusion Criteria: ● son/daughter in off-therapy Patients Inclusion Criteria: * age between 8 and 17 years old (included), undergoing treatment at the Pediatric Oncohematology departments (Day Hospital and hospitalization) * parents enrolled in the study * good understanding of the Italian language Patients Exclusion Criteria: ● patients in off-therapy
Where it's running
-
Ospedale San Gerardo, SC Ematologia Pediatrica
Monza, Monza-Brianza, Italy Recruiting -
SC Ematologia 2 - Oncoematologia pediatrica
Pavia, Pavia, Italy Recruiting -
Struttura Complessa di Pediatria e Oncoematologia Pediatrica, Ospedale SS Annunziata
Taranto, Taranto, Italy Recruiting
Study contacts
- Study coordinator: Marco Zecca, MD
- Email: m.zecca@smatteo.pv.it
- Phone: +390382501258
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.